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Abstract The PHO85 gene of Saccharomyces cerevisiae
encodes a cyclin-dependent protein kinase that can interact
with 10 different cyclins (Pcls). In conjunction with Pcl8p and
Pcl10p, Pho85p phosphorylates and regulates glycogen
synthase. Respiratory-deficient strains, such as coq3 mutants,
have reduced glycogen stores and contain hyperphosphorylated
and inactive glycogen synthase. We show here that pho85 coq3
mutants have dephosphorylated and active glycogen synthase
yet do not maintain glycogen reserves. In contrast, deletion of
PCL8 and PCL10 in the coq3 mutant background partially
restores glycogen accumulation. This suggested the existence of
inputs from Pho85p into glycogen storage, independent of Pcl8p
and Pcl10p, and acting antagonistically. ß 2002 Federation of
European Biochemical Societies. Published by Elsevier Science
B.V. All rights reserved.
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1. Introduction
In the yeast Saccharomyces cerevisiae, glycogen synthesis is
initiated in response to nutrient limitation, such as the ap-
proach to stationary phase [1]. The control of glycogen bio-
synthesis involves regulation of both the activity and the
abundance of glycogen synthase, which in yeast is encoded
by two genes, GSY1 and GSY2 [2]. GSY2 encodes the major,
nutritionally regulated form of the enzyme, and transcription
of GSY2 is increased on the approach to stationary phase by a
mechanism dependent upon cyclic AMP-dependent protein
kinase (PKA) [2^4].
In addition to transcriptional control, glycogen synthase is
regulated by covalent phosphorylation which occurs at C-ter-
minal sites and is inhibitory [5]. However, full activity can be
restored to the phosphorylated enzyme by addition of the al-
losteric activator, glucose 6-phosphate. This property forms
the basis for the 3/+ glucose-6-P activity ratio that is used
as an index of activation state. The phosphorylation of gly-
cogen synthase is catalyzed by at least two distinct kinases [6].
We have shown that one of these kinases comprises a complex
of the cyclin-dependent protein kinase Pho85p and the cyclin
Pcl10p [7,8]. A related cyclin, Pcl8p, is also implicated in the
control of glycogen synthase, although its precise role is less
well de¢ned [7]. Deletion of either PHO85 or both PCL8 and
PCL10 results in dephosphorylation and activation of glyco-
gen synthase which is accompanied, in rich media, by hyper-
accumulation of glycogen [6,7,9]. Ten di¡erent cyclin subunits
have been identi¢ed for Pho85p [10] and, recently, we have
established that the cyclins encoded by the PCL6 and PCL7
genes can also in£uence glycogen accumulation under certain
circumstances [11]. Furthermore, PKA contributes to post-
translational control of glycogen synthase activity although
it is most likely not by direct phosphorylation [3].
It has long been known that there is a link between the
ability of yeasts to respire and their ability to accumulate
glycogen [12]. When respiratory mutants are deprived of fer-
mentable carbon, they accumulate less glycogen than do wild
type cells. In addition to reduced glycogen, these mutants
have lowered ATP levels under the same conditions [12]. It
was therefore proposed that respiratory mutants failed to ac-
cumulate glycogen due to insu⁄cient energy reserves. More
recently an alternative explanation was o¡ered. Yang et al.
[13] suggested that strains containing mutations in genes
that are required for oxidative growth, such as COQ3, which
is required for the synthesis of coenzyme Q, failed to accumu-
late glycogen due to hyperphosphorylation and inactivation of
glycogen synthase [13]. In this work, the authors showed that
the glycogen-de¢cient phenotype of coq3 mutant cells could be
suppressed by the expression of non-phosphorylatable mu-
tants of glycogen synthase, or by mutations that inactivated
PKA. However, deletion of the PHO85 gene in coq3 mutant
cells did not restore glycogen accumulation. Therefore, the
authors concluded that the phosphorylation and inactivation
of glycogen synthase in respiratory-de¢cient cells occurred by
a mechanism that was independent of Pho85p function [13].
Here we show that phosphorylation of glycogen synthase in
respiratory mutants, as in wild type cells, is controlled by
Pho85p. Deletion of PHO85 in coq3 mutants led to dephos-
phorylation and activation of glycogen synthase, but the re-
sulting pho85 coq3 mutant cells remained glycogen-de¢cient
like coq3 mutants. In contrast, deletion of the PCL8 and
PCL10 genes in a coq3 mutant background was found to
partially suppress the glycogen de¢ciency, demonstrating
that Pho85p has inputs into glycogen storage that are inde-
pendent of Pcl8p and Pcl10p.
2. Materials and methods
2.1. Yeast strains and media
The yeast strains used in this study are detailed in Table 1. Stan-
dard methods for yeast culture and genetic manipulation were used
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[14]. Yeast cells were grown in synthetic complete medium (SC; con-
taining 0.67% (w/v) yeast nitrogen base, 2% (w/v) glucose, and com-
plete supplement mix (Bio 101)). For solid media, agar was added to
2% (w/v).
2.2. Growth of yeast in liquid culture
Cultures were grown overnight in SC medium. These cultures were
then used to inoculate fresh SC medium such that, after 24 h of
growth, a cell density of approximately 1U108 cells/ml was reached.
At this time, and again at 48 h post inoculation, aliquots were re-
moved for the determination of glycogen content or glycogen synthase
and glycogen phosphorylase activity as described below.
2.3. Enzyme assays
Glycogen synthase was assayed in extracts prepared from yeast cells
by lysis with glass beads as described previously [3,15]. Glycogen
phosphorylase activity was measured in the direction of glycogen syn-
thesis by monitoring the incorporation of [14C]glucose from
[14C]glucose 1-phosphate into glycogen using a modi¢cation of pub-
lished procedures [16,17].
2.3.1. Glycogen determination. Glycogen was assessed qualita-
tively by growing patches of cells on SC plates for 48 h and then
exposing the plates to iodine vapor. Cells stain brown in proportion
to the amount of glycogen they contain. Glycogen was determined
enzymatically as described previously [18].
2.3.2. Protein determination. The protein content was estimated
by the method of Bradford, using bovine serum albumin as a standard
[19].
3. Results
3.1. Inactivation of glycogen synthase in respiratory mutants is
dependent on Pho85p function
Respiratory mutants, such as coq3 cells that are defective in
the synthesis of ubiquinone, are de¢cient in glycogen storage.
Recently, this was attributed to hyperphosphorylation and
inactivation of glycogen synthase [13]. The PHO85 gene en-
codes the catalytic subunit of a cyclin-dependent protein ki-
nase which phosphorylates glycogen synthase. We were in-
trigued that deletion of PHO85 was reported not to
suppress the glycogen de¢cit of coq3 mutants, even though
expression of mutant glycogen synthase lacking the Pho85p
phosphorylation sites did. Although glycogen accumulation
was examined in pho85 coq3 mutants, the activation state of
glycogen synthase was not. It thus remained a possibility that
deletion of pho85 did activate glycogen synthase in coq3 mu-
tants but that pho85 coq3 mutants were unable to make gly-
cogen for other reasons. To address this issue, we measured
the 3/+ glucose-6-P activity ratio in extracts made from wild
type, coq3, pho85 and pho85 coq3 cells at two di¡erent points
during growth. Cultures were inoculated so that they reached
stationary phase (a density of V1U108 cells/ml) after 24 h of
growth, and samples were withdrawn for assay. Growth was
continued for a further 24 h and samples were again taken. As
reported by Yang et al. [13], coq3 mutants had an abnormally
low 3/+ glucose 6-P activity ratio late in growth (Fig. 1).
However, in pho85 coq3 mutants, this activity ratio was re-
stored and was even higher than wild type cells, resembling
that of pho85 mutants (Fig. 1). There was no signi¢cant
change in the total amount of glycogen synthase activity be-
tween the various strains (not shown). Consistent with pre-
vious results, when patches of either coq3 or pho85 coq3 mu-
tant cells were grown on synthetic medium and stained with
iodine vapor, both coq3 and pho85 coq3 cells were glycogen-
de¢cient (Fig. 2). Note that growth in synthetic medium re-
sults in higher glycogen accumulation by wild type cells than
does growth in rich medium, such that pho85 mutant cells do
not appear to hyperaccumulate glycogen under these condi-
tions.
Previously, we had demonstrated that the Pho85p cyclins,
Pcl8p and Pcl10p, direct Pho85p to phosphorylate glycogen
synthase [7] but their role in glycogen accumulation by coq3
mutants had not been investigated. Therefore, we analyzed a
pcl8 pcl10 coq3 triple mutant. The 3/+ glucose-6-P activity
ratio of glycogen synthase was elevated, as in pho85 coq3
mutants (Fig. 1), but in this case, glycogen storage was also
partially restored (Fig. 2).
The fact that the glycogen phenotype of pho85 coq3 and
pcl8 pcl10 coq3 mutants di¡ered suggests that PHO85 must
Table 1
Yeast strains used in this study
Strain Genotype Source or reference
EG328-1A MATK leu2 trp1 ura3-52 K. Tatchell
RY51 MATK leu2 trp1 ura3-52 coq3: :URA3 [13]
RY71 MATK leu2 trp1 ura3-52 pho85: :URA3 coq3: :TRP1 [13]
RY213 MATK leu2 trp1 ura3-52 pcl8: :TRP1 pcl10: :URA3 coq3: :URA3 R.C. Wek
WW10 MATK leu2 trp1 ura3-52 pcl8: :TRP1 pcl10: :LEU2 [8]
WW11 MATK leu2 trp1 ura3-52 pho85: :TRP1 [8]
WW13-28d MATK leu2 trp1 ura3-52 pho85: :URA3 pcl8: :URA3 pcl10: :URA3 coq3: :TRP1 This study
The wild type strain used was EG328-1A and all strains listed are isogenic.
Fig. 1. Glycogen synthase activity ratio in di¡erent strains. The in-
dicated strains were cultured in SC medium. Cultures were inoculat-
ed such that they reached saturation (V1U108 cells/ml) after 24 h
of growth. Samples were withdrawn at this 24 h time point (solid
bars) and again after 48 h growth (cross-hatched bars) and the gly-
cogen synthase 3/+ glucose-6-P activity ratio determined. The inset
shows the data for wild type and the coq3 mutant, expanded for
clarity. The data are the average of two independent experiments,
each of which was performed in duplicate. Strains used: wild type
(EG328-1A), coq3 (RY51), pho85 (WW11), pcl8 pcl10 (WW10),
pho85 coq3 (RY71), pcl8 pcl10 coq3 (RY213).
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have other inputs to control glycogen metabolism beyond the
known negative role of inactivating glycogen synthase. Fur-
thermore, there must be some positive input that either in-
creases glycogen synthesis or inhibits glycogen degradation.
Presumably these di¡erent functions would be carried out
by Pho85p in association with cyclins other than Pcl8p and
Pcl10p. This hypothesis predicts that the quadruple mutant
pho85 pcl8 pcl10 coq3 would have the glycogen phenotype
characteristic of pho85 coq3 cells rather than pcl8 pcl10 coq3
cells and this was indeed observed (Fig. 2).
3.2. Deletion of PHO85 increases glycogen phosphorylase
activity
To characterize better the glycogen phenotype of the coq3,
pho85 coq3 and pcl8 pcl10 coq3 mutants, we performed quan-
titative glycogen measurements after 24 h and 48 h growth in
liquid culture. At the 24 h time point, both wild type cells and
coq3 mutants accumulated equivalent amounts of glycogen
(Fig. 3). However, whilst wild type cells largely maintained
this store, coq3 mutants were de¢cient in glycogen by the 48
h time point, consistent with a recent report from the group of
Francois [20]. Similarly, pho85 coq3 mutant cells synthesized
glycogen but had degraded it by the 48 h time point whilst
pcl8 pcl10 coq3 mutants were at least partially capable of
maintaining glycogen stores.
Because coq3 and pho85 coq3 mutants exhibited accelerated
glycogen degradation relative to pcl8 pcl10 coq3 cells, we mea-
sured the activity of glycogen phosphorylase in the various
strains at the 24 h and 48 h time points. Glycogen phosphor-
ylase activity was found to be substantially increased in both
pho85 and pho85 coq3 mutant cells compared to either wild
type, coq3, pcl8 pcl10 or pcl8 pcl10 coq3 cells, and this was
most obvious at the 48 h time point (Fig. 4). Therefore, whilst
deletion of PHO85 leads to dephosphorylation and activation
of glycogen synthase, it also results in an increase in glycogen
phosphorylase activity. The increased glycogen phosphorylase
activity is not seen in pcl8 pcl10 or pcl8 pcl10 coq3 mutants
and thus, the control which Pho85p exerts over glycogen
phosphorylase is achieved via interaction with other cyclins.
4. Discussion
Over 30 years ago Chester [12] reported that the inability of
yeast cells to respire correlated with an inability to store gly-
cogen. This observation was attributed to the fact that respi-
ratory-de¢cient cells growing in glucose-depleted medium had
decreased ATP levels, and hence the diminished energy supply
failed to support glycogen synthesis. Recently, an alternative
explanation was o¡ered [13]. It was shown that glycogen syn-
thase was hyperphosphorylated and inactivated in respiratory
mutants, such as coq3 strains. Furthermore, deletion of
PHO85 in a coq3 strain did not restore glycogen accumula-
Fig. 2. Glycogen levels in di¡erent yeast strains. The indicated
strains were grown for 48 h on SC plates. Glycogen accumulation
was then assessed by exposing the agar plate to iodine vapor. Cells
stain brown in proportion to the amount of glycogen present.
Strains used: wild type (EG328-1A), coq3 (RY51), pho85 (WW11),
pcl8 pcl10 (WW10), pho85 coq3 (RY71), pcl8 pcl10 coq3 (RY213),
pho85 pcl8 pcl10 coq3 (WW13-28d).
Fig. 3. Glycogen accumulation early and late in saturated culture.
The indicated strains were cultured in SC medium as described in
the legend to Fig. 1. Samples were withdrawn at this 24 h time
point (solid bars) and again after 48 h growth (cross-hatched bars)
and the glycogen content was determined. The data shown are the
average of two independent experiments, each of which was per-
formed in duplicate. Strains used: wild type (EG328-1A), coq3
(RY51), pho85 (WW11), pcl8 pcl10 (WW10), pho85 coq3 (RY71),
pcl8 pcl10 coq3 (RY213).
Fig. 4. Glycogen phosphorylase activity early and late in saturated
culture. The indicated strains were grown as described in the legend
to Fig. 1. Glycogen phosphorylase activity was measured after 24 h
(solid bars) and 48 h (cross-hatched bars) growth. The data shown
are the average of two independent experiments, each of which was
performed in duplicate.
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tion, leading to the conclusion that the phosphorylation and
inactivation of glycogen synthase in respiratory-de¢cient cells
occurred by a mechanism that was independent of Pho85p
function [13]. We show here that the defective glycogen stor-
age exhibited by coq3 mutants is not impaired synthesis but
rather an inability to maintain glycogen once it is made. Early
in stationary phase, both wild type cells and coq3 mutants
have accumulated equivalent levels of glycogen. However,
whereas wild type cells maintained this glycogen for an ex-
tended period of time, the store was more rapidly depleted in
coq3 mutants. We con¢rmed the report that deletion of
PHO85 was unable to suppress the glycogen defect of coq3
mutants but found additionally that deletion of the Pho85p
cyclins encoded by the PCL8 and PCL10 genes could partially
suppress the glycogen de¢cit of coq3 mutants. Furthermore, in
either pho85 coq3 or pcl8 pcl10 coq3 mutants, the glycogen
synthase 3/+ glucose-6-P activity ratio was greatly elevated,
resembling pho85 or pcl8 pcl10 mutants. Therefore, the phos-
phorylation state of glycogen synthase in respiratory mutants,
as in wild type cells, is regulated by Pho85p and the cyclins
Pcl8p and Pcl10p, and the failure of coq3 mutants to maintain
glycogen cannot be explained solely in terms of the glycogen
synthase activation.
Our view is that the results of Yang et al. [13], and our own
results, are best explained as follows. The amount of glycogen
at any time is a function of the rates of synthesis and break-
down. Expression of non-phosphorylatable glycogen synthase
or deletion of PCL8 and PCL10 both increase glycogen syn-
thesis because they bypass the phosphorylation control of
glycogen synthase. Thus, whatever the mechanism that leads
to increased phosphorylation of glycogen synthase in coq3
mutants, it is blocked in these cells, the balance is tipped in
favor of glycogen synthesis and glycogen accumulates. How-
ever, coq3 mutants cannot utilize non-fermentable carbon
sources, such as ethanol, for growth and the glycogen reserves
are consumed in order to support growth once glucose is
depleted from the medium. Therefore, even when phosphory-
lation of glycogen synthase is blocked, cells with the coq3
mutation cannot maintain glycogen stores in the long term.
This is apparent from Fig. 2 where the older pcl8 pcl10 coq3
cells at the center of the colony have lost glycogen but the
younger cells at the periphery still retain the polysaccharide.
Similar conclusions have been reached by Francois’s group
[20]. Additionally, Enjalbert et al. [20] reported an activation
of glycogen phosphorylase in respiratory mutants which they
attributed to decreased cellular glucose-6-P. Glucose-6-P is
both an inhibitor of glycogen phosphorylase and an activator
of glycogen synthase, making this scheme logical. However, in
our strain background and with the growth conditions used in
the present work, we could not detect any increase in phos-
phorylase activity in the coq3 mutants when compared to wild
type. However, if glycogen synthesis is decreased, be it by
increased phosphorylation of glycogen synthase, a reduction
in glucose-6-P or some other mechanism, then, as long as
there is some glycogen phosphorylase activity, the net result
will be decreased glycogen storage.
The observation that glycogen accumulation in pho85 coq3
mutants resembled coq3 mutants, whilst pcl8 pcl10 coq3 mu-
tants were not so severely de¢cient, led us to conclude that
Pho85p had inputs into glycogen storage which were indepen-
dent of Pcl8p and Pcl10p. Since the coq3 and pho85 coq3
mutants exhibited accelerated glycogen degradation relative
to pcl8 pcl10 coq3 mutants or wild type cells, an obvious
possibility was that deletion of PHO85 led to activation of
glycogen phosphorylase. We found there was about ¢ve-fold
higher phosphorylase activity in pho85 and pho85 coq3 mu-
tants compared to either wild type or pcl8 pcl10 coq3 cells.
Thus, the positive input which Pho85p has to glycogen stor-
age appears to be a downregulation of phosphorylase activity
(Fig. 5).
We recently obtained a separate body of evidence linking
Pho85p to the control of glycogen phosphorylase [11]. We
found that glycogen storage could be restored to snf1 mu-
tants, in which glycogen synthase was phosphorylated and
inactive, by deletion of PHO85, but not by deletion of
PCL8 and PCL10. We went on to show that deletion of
both PCL6 and PCL7 in a snf1 pcl8 pcl10 mutant resulted
in a restoration of glycogen accumulation. We do not believe
that control of glycogen phosphorylase by Pho85p occurs
solely via Pcl6p and Pcl7p since deletion of PCL6 and
PCL7 in wild type cells increases phosphorylase activity
only about two-fold, compared to the about ¢ve-fold increase
when PHO85 is deleted (Wilson and Roach, unpublished ob-
servation). Currently, experiments are under way to address
precisely how Pho85p regulates glycogen phosphorylase activ-
ity.
Although it might at ¢rst sight seem teleologically illogical
to have a single kinase catalytic subunit, Pho85p, involved in
both the positive and negative regulation of glycogen storage,
it is important to realize that the functional identity of this
kinase is conferred by the nature of the associated regulatory
subunit. We have previously suggested that a pool of the
Pho85p free catalytic subunit is always present and is re-
Fig. 5. Multiple inputs of Pho85p into the regulation of glycogen
accumulation. The model shows the relationships between the genes
and alleles studied. PHO85 regulates glycogen storage both posi-
tively and negatively via interaction with di¡erent cyclin subunits.
In association with Pcl8p or Pcl10p, Pho85p phosphorylates and in-
activates glycogen synthase, promoting reduced glycogen storage.
However, Pho85p, in complex with Pcl6p, Pcl7p or an unde¢ned
Pcl protein, also negatively regulates glycogen phosphorylase activ-
ity, leading to increased glycogen storage. Although the Pho85p cat-
alytic subunit is common to the di¡erent kinase complexes, their
speci¢city is de¢ned by the associated Pcl protein and each kinase
complex could be regulated independently in response to di¡erent
signals. When glucose is depleted, respiratory mutants such as coq3,
which are unable to utilize non-fermentable carbon sources, begin
to starve and show increased phosphorylation of glycogen synthase
that can be blocked by mutation of PHO85 or PCL8 and PCL10.
Therefore, a signal that activates Pho85p/Pcl8,10p is probably gener-
ated in response to energy limitation.
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cruited, by individual cyclins, to speci¢c tasks as conditions
demand [8]. Consistent with this view, di¡erent Pho85p/Pcl
complexes can be subject to di¡erent types of regulation
and be responsive to distinct signals.
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